| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
|
23,155 |
1,831 |
$791K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
23,133 |
1,230 |
$83K |
| J1756 |
Injection, iron sucrose, 1 mg |
3,742 |
831 |
$15K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
9,862 |
823 |
$13K |
| 85048 |
|
606 |
559 |
$0.00 |
| 83970 |
|
330 |
312 |
$0.00 |
| 83540 |
|
288 |
256 |
$0.00 |
| 85041 |
|
606 |
559 |
$0.00 |
| A4657 |
Syringe, with or without needle, each |
890 |
861 |
$0.00 |
| 83550 |
|
288 |
256 |
$0.00 |
| 82728 |
|
279 |
258 |
$0.00 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
90 |
52 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
24 |
24 |
$0.00 |